BIOL - Biolase Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 SPY (-4.50%) USO (4.04%) VXX (8.59%) WMT (0.46%) SLB (-6.68%) ROKU (-5.79%) RH (-11.79%) QQQ (-4.25%) QDEL (0.74%) PNNT (-10.04%) PINS (-8.23%) OKTA (-2.2%) OIH (-6.47%) NVDA (-7.79%) MU (-5.16%) MRNA (-0.94%) MFGP (-9.87%) KLXE (-19.62%) HPQ (-14.52%) GNC (-10.9%) GGAL (-3.69%) GE (-11.34%) ENDP (-17.03%) CBRL (-11.85%) BABA (-3.56%)

BIOL - Biolase

$0.25 -0.13[-33.34%]

15 mins delayed data

People also watch :

+Watchlist

1 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$0.38	Open	$0.38
Volume	1.64M	Market Cap	35.56M
Yield		Last Dividend

Day

52 Week

The Daily Biotech Pulse: InflaRx Begins ...	6:38 AM
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 31) At...

The Daily Biotech Pulse: Pfizer's Eczema...	03/19/20
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18)...

BIOLASE Announces Clearance of the Epic ...	12/09/19
IRVINE, Calif., Dec. 9, 2019 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced the launch of their new Epic ...

BIOLASE Announces Schedule Of Investor C...	11/26/19
IRVINE, Calif., Nov. 26, 2019 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it has been invited to...

BIOLASE Appoints Michael DiTolla, DDS, F...	11/15/19
IRVINE, Calif., Nov. 15, 2019 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it appointed Michael D...

BIOLASE : Reports Third Quarter 2019 Res...	11/06/19
BIOLASE Reports Third Quarter 2019 Results Download as PDFNovember 06, 2019 4:05pm EST Related Documents Audio ??? \| November 6, 2019

The Daily Biotech Pulse: FDA Approves Cl...	10/09/19
The following is a roundup of top developments in the biotech space over the last 24 hours. None of the NYSE or Nasdaq-listed biotech stocks hit 52-we...

Biolase's (BIOL) CEO Todd Norbe on Q1 20...	05/11/19
No summary available.

Biolase misses by $0.03, misses on reven...	05/09/19
No summary available.

BIOLASE, Inc. (BIOL) CEO Todd Norbe on Q...	03/05/19
No summary available.

Biolase beats by $0.05, beats on revenue	03/05/19
No summary available.

Mallinckrodt and Aerie Pharmaceuticals a...	02/26/19
No summary available.

BIOLASE up 26%	02/13/19
No summary available.

Biolase up 4% on cross-promotion deal wi...	01/29/19
No summary available.

ANALYST RATINGS

0 analyst ratings (Last 6 months)

0.00 %

Strong Buy + Buy

Price Target (PT)

EARNINGS

Date	2020-03-26 (AMC)	Est. (EPS/Rev.)	($0.05)/ 13.33M
Actual (EPS/Rev.)	$-0.13/ $10.18 M	EPS (TTM)	0

TRADERS TRACKING $BIOL

Service Name	Trader	% Success
Arbitrage Trade Analytics	Royce Wells	71.00 %	Subscribe

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Follow Us

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.